Cargando…
Ablative Therapies for Breast Cancer: State of Art
Breast cancer (BC) is the most frequently diagnosed malignancy among women. In the past two decades, new technologies and BC screening have led to the diagnosis of smaller and earlier-stage BC (ESBC). Therefore, percutaneous minimally invasive techniques (PMIT) were adopted to treat patients unfit f...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017926/ https://www.ncbi.nlm.nih.gov/pubmed/36916200 http://dx.doi.org/10.1177/15330338231157193 |
_version_ | 1784907698126454784 |
---|---|
author | Carriero, Serena Lanza, Carolina Pellegrino, Giuseppe Ascenti, Velio Sattin, Caterina Pizzi, Caterina Angileri, Salvatore Alessio Biondetti, Pierpaolo Ianniello, Andrea Antonio Piacentino, Filippo Lavorato, Roberto Ierardi, Anna Maria Carrafiello, Gianpaolo |
author_facet | Carriero, Serena Lanza, Carolina Pellegrino, Giuseppe Ascenti, Velio Sattin, Caterina Pizzi, Caterina Angileri, Salvatore Alessio Biondetti, Pierpaolo Ianniello, Andrea Antonio Piacentino, Filippo Lavorato, Roberto Ierardi, Anna Maria Carrafiello, Gianpaolo |
author_sort | Carriero, Serena |
collection | PubMed |
description | Breast cancer (BC) is the most frequently diagnosed malignancy among women. In the past two decades, new technologies and BC screening have led to the diagnosis of smaller and earlier-stage BC (ESBC). Therefore, percutaneous minimally invasive techniques (PMIT) were adopted to treat patients unfit for surgery, women who refuse it, or elderly patients with comorbidities that could make surgery a difficult and life-threatening treatment. The target of PMIT is small-size ESBC with the scope of obtaining similar efficacy as surgery. Minimally invasive treatments are convenient alternatives with promising effectiveness, lower morbidity, less cost, less scarring and pain, and more satisfying cosmetic results. Ablative techniques used in BC are cryoablation, radiofrequency ablation, microwave ablation, high-intensity focused ultrasound (US), and laser ablation. The aim of our study is to discuss the current status of percutaneous management of BC, evaluate the clinical outcomes of PMIT in BC, and analyze future perspectives regarding ablation therapy in BC. |
format | Online Article Text |
id | pubmed-10017926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-100179262023-03-17 Ablative Therapies for Breast Cancer: State of Art Carriero, Serena Lanza, Carolina Pellegrino, Giuseppe Ascenti, Velio Sattin, Caterina Pizzi, Caterina Angileri, Salvatore Alessio Biondetti, Pierpaolo Ianniello, Andrea Antonio Piacentino, Filippo Lavorato, Roberto Ierardi, Anna Maria Carrafiello, Gianpaolo Technol Cancer Res Treat New Tools in Loco-Regional Treatments: State of Art and Future Directions Breast cancer (BC) is the most frequently diagnosed malignancy among women. In the past two decades, new technologies and BC screening have led to the diagnosis of smaller and earlier-stage BC (ESBC). Therefore, percutaneous minimally invasive techniques (PMIT) were adopted to treat patients unfit for surgery, women who refuse it, or elderly patients with comorbidities that could make surgery a difficult and life-threatening treatment. The target of PMIT is small-size ESBC with the scope of obtaining similar efficacy as surgery. Minimally invasive treatments are convenient alternatives with promising effectiveness, lower morbidity, less cost, less scarring and pain, and more satisfying cosmetic results. Ablative techniques used in BC are cryoablation, radiofrequency ablation, microwave ablation, high-intensity focused ultrasound (US), and laser ablation. The aim of our study is to discuss the current status of percutaneous management of BC, evaluate the clinical outcomes of PMIT in BC, and analyze future perspectives regarding ablation therapy in BC. SAGE Publications 2023-03-14 /pmc/articles/PMC10017926/ /pubmed/36916200 http://dx.doi.org/10.1177/15330338231157193 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | New Tools in Loco-Regional Treatments: State of Art and Future Directions Carriero, Serena Lanza, Carolina Pellegrino, Giuseppe Ascenti, Velio Sattin, Caterina Pizzi, Caterina Angileri, Salvatore Alessio Biondetti, Pierpaolo Ianniello, Andrea Antonio Piacentino, Filippo Lavorato, Roberto Ierardi, Anna Maria Carrafiello, Gianpaolo Ablative Therapies for Breast Cancer: State of Art |
title | Ablative Therapies for Breast Cancer:
State of Art |
title_full | Ablative Therapies for Breast Cancer:
State of Art |
title_fullStr | Ablative Therapies for Breast Cancer:
State of Art |
title_full_unstemmed | Ablative Therapies for Breast Cancer:
State of Art |
title_short | Ablative Therapies for Breast Cancer:
State of Art |
title_sort | ablative therapies for breast cancer:
state of art |
topic | New Tools in Loco-Regional Treatments: State of Art and Future Directions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017926/ https://www.ncbi.nlm.nih.gov/pubmed/36916200 http://dx.doi.org/10.1177/15330338231157193 |
work_keys_str_mv | AT carrieroserena ablativetherapiesforbreastcancerstateofart AT lanzacarolina ablativetherapiesforbreastcancerstateofart AT pellegrinogiuseppe ablativetherapiesforbreastcancerstateofart AT ascentivelio ablativetherapiesforbreastcancerstateofart AT sattincaterina ablativetherapiesforbreastcancerstateofart AT pizzicaterina ablativetherapiesforbreastcancerstateofart AT angilerisalvatorealessio ablativetherapiesforbreastcancerstateofart AT biondettipierpaolo ablativetherapiesforbreastcancerstateofart AT iannielloandreaantonio ablativetherapiesforbreastcancerstateofart AT piacentinofilippo ablativetherapiesforbreastcancerstateofart AT lavoratoroberto ablativetherapiesforbreastcancerstateofart AT ierardiannamaria ablativetherapiesforbreastcancerstateofart AT carrafiellogianpaolo ablativetherapiesforbreastcancerstateofart |